Heat-stable antifungal factor (HSAF) belongs to polycyclic tetramate macrolactams (PTMs), which inhibits many fungal pathogens and is effective in inhibiting the Candida albicans (C. albicans). In this study, we found that HSAF induced the apoptosis of Candida albicans SC5314 through inducing the production of reactive oxygen species (ROS). Nevertheless, we validated the efficacy of HSAF against candidiasis caused by C. albicans in murine model in vivo, and HSAF 
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Introduction
In recent decades, the incidence and frequency of invasive fungal infections were widespread and there was a sharpen increase in mortality due to mycoses, especially in the population of immuncompromised patients. Fungal infections are a major source of global morbidity and mortality, especially for the species of Candida and
Aspergillus.
1 Therefore, how to treat the C. albicans infection has attracted the aberrant deposition of thick cell wall patches to inhibit the growth of Aspergillus nidulans, and proposed that the antifungal activity of HSAF was mediated by disrupting the biosynthesis of ceramide. 9 Though great efforts have been made to investigate the mode of action of HSAF, the cellular biological mechanisms and the target of HSAF are still unknown. Ceramides have been reported to have effects on mitochondria including enhanced generation of reactive oxygen species (ROS). 10 Recent studies have reported that major classes of antibiotics contribute to induce apoptosis via the production of ROS. 11 Therefore, to determine whether or not HSAF induced apoptosis in C. albicans through ROS accumulation, we investigated various apoptotic features after treatment with HSAF. In this study, we reported the antifungal activity of HSAF against filamentous pathogenic fungi, yeast and filamentous forms of C. albicans in vitro. Nevertheless, we validated the efficacy of HSAF against candidiasis caused by C. albicans in mice model in vivo. We investigated the antifungal mechanism of HSAF using RNA-seq technology, morphological, and molecular assays to confirm its mode of action and found that HSAF exhibited potent anti-Candida activity, arresting cells at G2/M phase and triggering apoptosis via an ROS dependent pathway.
Experimental section Fungal strains and growth conditions
The filamentous pathogenic fungi were maintained on potato dextrose agar (PDA) medium including 20% potato, 2% dextrose and 2% agar at 25 °C for 5 d. C. albicans (ATCC 5314) were used for all experiments described and were cultured in YPD HSAF for 4 or 8 h, meanwhile adding 1 mM and 5 mM ascorbic acid (AA) for 30 min prior to the addition of 24 µg/mL HSAF and then washed with PBS three times, permeabilized in a permeabilization buffer (0.1% sodium citrate and 0.1% Triton X-100) on ice for 10 min and washed again with PBS three times. DNA ends were labeled with an in situ cell death detection kit at 37 °C for 1 h. Nuclear condensation was analyzed by DAPI staining 16 and then analyzed by fluorescence microscope (OLYMPUS, IX71, Japan) using a 63 × objective.
Polymerization assay
The ability of tubulin to polymerize into microtubules can be followed by observing an increase in optical density of a tubulin solution at OD 340 . Tubulin protein from porcine brain was reconstituted to 5 mg/ml with cold tubulin buffer (80 mM PIPES, pH 6.9, 2 mM MgCl 2 , 0.5 mM EGTA). The tubulin solution (at 4°C), which was plus 5% glycerol and 1 mM GTP adding 10 µM HSAF or 10 µM vincristine (vin), was transferred into a microtiter plate, which had been pre-warmed to 37°C. Tubulin polymerization was measured by taking readings every 30 s for 30 min. Absorbance at 340 mm was monitored in the spectrophotometer.
Molecular modeling studies
All the molecular modeling were performed on a Dell Precision T5500
workstation. The molecular docking was conducted using SYBYL-X 1.1 (Tripos, St.
Louis, MO, USA). The wild type and mutant strains of C. albicans β-tubulin proteins were built by SWISS-MODEL, a fully automated protein structure homology-modelling server [17] [18] [19] [20] . The compound HSAF was optimized for 1000-generations until the maximum derivative of energy became 0.05 kcal/(mol*Å), using the Tripos force field. Charges were computed and added according to
Gasteigere Hückel parameters. The optimized HSAF was docked into the binding site of C. albicans β-tubulin proteins by means of surflex-dock, and the default parameters were used if it was not mentioned. Then a molecular dynamic (MD) study was performed to revise the docking result.
The Amber 12 and AmberTools 13 programs 21 were used for MD simulations of the selected docked pose. Compound HSAF was first prepared by ACPYPE 22 , a tool based on ANTECHAMBER for generating automatic topologies and parameters in different formats for different molecular mechanics programs, including calculation of partial charges. Then, the forcefield "leaprc.gaff" (generalized amber forcefield) was used to prepare the ligand, while "leaprc.ff12SB" was used for the receptor. The system was placed in a rectangular box (with a 10.0 Å boundry) of TIP3P water using the "SolvateOct" command with the minimum distance between any solute atoms.
Equilibration of the solvated complex was done by carrying out a short minimization (1000 steps of each steepest descent and conjugate gradient method), 500 ps of heating, and 200 ps of density equilibration with weak restraints using the GPU (NVIDIA® Tesla K20c) accelerated PMEMD (Particle Mesh Ewald Molecular Dynamics) module. At last, 20 ns of MD simulations were carried out.
In vivo assay for antifungal activity
To evaluate the effect of HSAF on C. albicans in vivo, a total of fifty male BALB/c mice (6-8 weeks old) were obtained from the Experimental Animal Center of RNA-seq technology provided a useful tool for transcriptome analysis and it offered broad and deep insights into gene regulatory networks and biological pathways. 24 Based on transcriptional sequencing and analysis, we first identified differentially expressed genes (DEGs) between the untreated and treated cells with HSAF. Moreover, we identified important regulatory genes involved in the ROS pathway. These results will be helpful for elucidating the molecular mechanisms of HSAF effecting on fungi.
HSAF induced total intracellular ROS levels increasing and triggered collapse of mitochondrial membrane potential (△Ψm)
In order to determine if the mechanism of killing by HSAF was ROS mediated, we examined ROS levels of C. albicans cells treated with or without HSAF by fluorimetric assay. Generation of ROS was monitored by incubation of HSAF at 3, 6
and 12 µg/mL with the Candida cells for 1, 2, and 3 h, respectively. ROS levels were slightly elevated in Candida cells after exposure to HSAF at low concentrations for 2 h. Moreover, high concentration of HSAF treatment caused a marked ROS increase in Candida cells after 2 h (Fig. 3A) . These findings indicated that HSAF could induce the ROS accumulation in C. albicans cells in a time-and dose-dependent manner.
Previous study suggested that mitochondrial ROS triggered cell apoptosis may occur via formation of the mitochondrial permeability transition pore complex, a crucial step in mitochondrial demolition. 25 DiOC 6 (3) is a mitochondrial dye that aggregates into healthy mitochondria and fluoresces green and it is specifically used 3B ). The result showed that HSAF effect was related to the dissipation of △Ψm.
To determine whether the elevated ROS in Candida cells contributes to HSAF-induced cell death, the anti-Candida activity of HSAF without and with the ROS scavengers, ascorbic acid (AA), acetyl cysteine (NAC), glutathione (GSH) and thiourea (TU) were examined. We found that exposing exponentially growing C.
albicans to 0.5 mM AA or 5 mM TU, the MIC of HSAF increased to 100 µg/mL ( Fig.   3C ) and diminished the toxicity of HSAF, reducing killing by about 30-fold at 3 h (Fig. 3C) .
HSAF induced G2 cell cycle arrest and apoptosis in C. albicans through inducing the production of reactive oxygen species
To study the effect of HSAF on cell cycle progression, flow cytometry analysis was performed. We observed that HSAF treatment led to more cells accumulating in phenotype as an early marker of apoptosis, whereas this phenomenon was rarely observed in 3 and 6 µg/mL HSAF-treated cells for 4 h. Exposure to 3 and 6 µg/mL HSAF for 8 h caused early apoptosis in C. albicans (Fig. 4B ). This indicated that HSAF induced early apoptosis in C. albicans in a time-and dose-dependent manner.
A TUNEL assay was performed to investigate nuclear morphological features of the late stage of apoptosis in C. albicans. 31 The cells of C. albicans treated with 3 µg/mL HSAF cannot induce the late apoptosis at 4 h, and the DNA fragments were observed when the cells treated with 3 µg/mL HSAF at 8 h (Fig. 4B) . The cells treated with 24 µg/mL HSAF exhibited a significant amount of changed in the nuclear DNA for 4 h, consistent with the positive control, which treated with 10 µg/mL AMB, as assessed by the DNA-binding fluorescent dye DAPI (Fig. 4D ). In the DMSO treated population, chromatin appeared as single round nuclei appearance. The similar results
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were obtained by TUNEL assay (Fig. 4E) , which is one of the most reliable ways for the identification of the late stages of apoptosis in yeast. 32 Either at early or late apoptosis stage, when added with 1 mM AA, the intensity of fluorescence changed weak, the antifungal activity of HSAF decreased, while added with 5 mM ascorbic acid, HSAF lost the antifungal activity (Fig. 4C, D, E) . The results suggest that HSAF has a critical effect on apoptotic cellular changes either early or late apoptosis through inducing the accumulation of ROS. It was in a nice dose and time dependent manner.
HSAF inhibited the polymerization of β β β β-tubulin
HSAF disrupted mitochondrial membrane potential, arrested the cell cycle at the G2/M phase, and induced apoptosis, a hallmark of microtubule destabilizing drugs. 33 Moreover, mitochondria may connect microtubule damage to the apoptotic machinery, acting as appropriate, and timing switches for the onset of apoptosis. 34 According to these observations. We tested whether HSAF directly inhibited tubulin polymerization in vitro. HSAF were assayed for inhibition of tubulin polymerization in a biochemical assay using purified tubulin isolated from porcine brain. HSAF strongly inhibited tubulin polymerization under 340 nm in vitro. A similar activity was exhibited by vinblastine ( Fig. 5A ).
To better elucidate the detailed interactions between HSAF and β-tubulin at the molecular level and to understand the structural basis of their binding mode, a docking study of HSAF was first performed using SYBYL-X 1.1 and then MD Taken together, our molecular simulation allowed us to rationalize the activity profile of the HSAF against β-tubulin, which provided valuable information for further design of novel effective β-tubulin inhibitors.
HSAF inhibited C. albicans in vivo
In order to relate the in vitro cytotoxicity with in vivo effects, a number of toxicity experiments were performed on a murine model of disseminated infection due 
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Graphical Abstract HSAF, isolated from Lyaobacter enzymogenes C3, was a potent antifungal with a broad spectrum of activity. HSAF induced the apoptosis of Candida albicans through inducing the production of reactive oxygen species (ROS). The binding model of HSAF to β-tubulin was simulated by Amber12 and shown by PyMoL.
